CD274 and non-small cell lung carcinoma: Given the problems with current IHC testing, our study sought to evaluate the potential clinical utility of transcriptomic PD-L1 in a cohort of NSCLC patient tumors simultaneously tested by standard IHC and by RNA-seq.